Besides their anti-inflammatory action, GCs might also exert several adverse effects, with hyperglycemia and hyperinsulinemia being one of the major drawbacks of their long-term use mainly through a direct transcriptional effect of activated GR on gluconeogenic enzymes by transactivation mechanisms. Here, NR3C1 is linked to hyperinsulinism.